These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26756583)

  • 21. Clinical significance of LOXL4 expression and features of LOXL4-associated protein-protein interaction network in esophageal squamous cell carcinoma.
    Xie W; Huang P; Wu B; Chen S; Huang Z; Wang J; Sun H; Wu J; Xie L; Cheng Y; Xie W; Xu L; Chen LQ; Li E; Zou H
    Amino Acids; 2019 May; 51(5):813-828. PubMed ID: 30900087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.
    Sun ZJ; Yu GT; Huang CF; Bu LL; Liu JF; Ma SR; Zhang WF; Liu B; Zhang L
    Oncotarget; 2016 Mar; 7(10):11651-63. PubMed ID: 26872381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma.
    Goto RN; Sobral LM; Sousa LO; Garcia CB; Lopes NP; Marín-Prida J; Ochoa-Rodríguez E; Verdecia-Reyes Y; Pardo-Andreu GL; Curti C; Leopoldino AM
    Eur J Pharmacol; 2018 Jan; 819():198-206. PubMed ID: 29221949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
    Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
    Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW
    Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC.
    Nakamura Y; Togashi Y; Nakahara H; Tomida S; Banno E; Terashima M; Hayashi H; de Velasco MA; Sakai K; Fujita Y; Okegawa T; Nutahara K; Hamada S; Nishio K
    Mol Cancer Ther; 2016 Aug; 15(8):1988-97. PubMed ID: 27207775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
    Schrijvers AH; Quak JJ; Uyterlinde AM; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Sep; 53(18):4383-90. PubMed ID: 8364934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.
    Rosenthal EL; Kulbersh BD; King T; Chaudhuri TR; Zinn KR
    Mol Cancer Ther; 2007 Apr; 6(4):1230-8. PubMed ID: 17431103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
    Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
    Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
    Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
    Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of seven newly established head and neck squamous cell carcinoma cell lines.
    Görögh T; Quabius ES; Meyer P; Hoffmann M
    Eur Arch Otorhinolaryngol; 2015 May; 272(5):1251-8. PubMed ID: 24792014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.
    Farnebo L; Shahangian A; Lee Y; Shin JH; Scheeren FA; Sunwoo JB
    Oncotarget; 2015 Apr; 6(12):9897-907. PubMed ID: 25846753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
    Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
    Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
    [No Abstract]   [Full Text] [Related]  

  • 36. Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer.
    Kasashima H; Yashiro M; Okuno T; Miki Y; Kitayama K; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    Digestion; 2018; 98(4):238-248. PubMed ID: 30045039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma.
    Yin X; Hayes DN; Shores CG
    Head Neck; 2011 Aug; 33(8):1106-14. PubMed ID: 20967867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
    Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
    J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ammonium tetrathiomolybdate enhances the antitumor effects of cetuximab via the suppression of osteoclastogenesis in head and neck squamous carcinoma.
    Morisawa A; Okui T; Shimo T; Ibaragi S; Okusha Y; Ono M; Nguyen TTH; Hassan NMM; Sasaki A
    Int J Oncol; 2018 Mar; 52(3):989-999. PubMed ID: 29328370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.